Showing 5931-5940 of 6035 results for "".
- Neuro-Optometric Rehabilitation Association (NORA) Launches Redesigned Website; Accepts Award Nominationshttps://modernod.com/news/neuro-optometric-rehabilitation-association-nora-launches-redesigned-website-accepts-award-nominations/2480061/The Neuro-Optometric Rehabilitation Association, International (NORA) announced the launch of its redesigned website and new domain name, www.noravisionrehab.org, dedicated to educating patients, caregivers, and health care professionals about neurolog
- Market Scope: New Products Poised to Drive Glaucoma Pharma Market to $6.6 Billion by 2023https://modernod.com/news/market-scope-new-products-poised-to-drive-glaucoma-pharma-market-to-6-6-billion-by-2023/2480067/The launches of Vyzulta, Rhopressa, and preservative-free formulations promise to boost manufacturers’ revenues during the next 5 years in the global glaucoma pharmaceuticals market. The upswing follows years of declining revenues as branded products lost patent protection and the market s
- Staar Surgical and Kobe Kanagawa Eye Clinic in Japan Announce Strategic Cooperation Agreementhttps://modernod.com/news/staar-surgical-and-kobe-kanagawa-eye-clinic-in-japan-announce-strategic-cooperation-agreement/2480068/Staar Surgical and Kobe Kanagawa Eye Clinic, with locations in Tokyo and Osaka, announced they have entered into a multi-year Strategic Cooperation Agreement to provide Staar’s EVO Visian ICL lenses as a primary and premium option for patients seeking visual freedom from spectacles and cont
- Iridex Announces Multiple Studies of MicroPulse Laser Therapy Published at WOChttps://modernod.com/news/iridex-announces-multiple-studies-of-micropulse-laser-therapy-published-at-woc/2480069/Iridex announced new data was released at the World Ophthalmology Congress in Barcelona showing that MicroPulse Laser Therapy with the MicroPulse P3 Glaucoma Device is safe and effective. New real-world data shows a reduction in IOP close to 50%, with new morphological i
- Intraocular Robotic Surgery Feasible: First-in-Human Studyhttps://modernod.com/news/intraocular-robotic-surgery-feasible-first-in-human-study/2480072/For the first time in humans, a remotely controlled electronic robotic device has been used to perform highly precise intraocular surgery, according to a Reuters report. “The robot has the potential to operate with far more pr
- RightEye Unveils EyeQ Trainer Personalized Computer-Based Vision Training Systemhttps://modernod.com/news/righteye-unveils-eyeq-trainer-personalized-computer-based-vision-training-system/2480076/RightEye unveiled its new EyeQ Trainer computer-based vision rehabilitation program at Optometry’s Meeting 2018 in Denver, Colorado (RightEye booth #611). EyeQ Trainer gives optometrists a tool their
- Foundation Fighting Blindness Launches the Stargardt Disease Natural History Studyhttps://modernod.com/news/foundation-fighting-blindness-launches-the-stargardt-disease-natural-history-study/2480086/More than 60 leading retinal disease clinical researchers from around the world gathered in Baltimore on June 11, 2018 to discuss findings from ProgStar, the Stargardt disease natural history study launched by the Foundation Fighting
- OD-OS Introduces the Navilas expertLibrary Forum for Retina Specialistshttps://modernod.com/news/od-os-introduces-the-navilas-expertlibrary-forum-for-retina-specialists/2480093/OD-OS has introduced a new forum for retina specialists – the Navilas expertLibrary. The Navilas expertLibrary is an exclusive forum where leading retinal physicians share their day-to-day experience with this novel navigated retinal laser technology, according to OD-OS. Interested parties
- GenSight Biologics Reports Positive Additional Data From REVERSE Phase 3 Clinical Trial of GS010 for Treatment of LHONhttps://modernod.com/news/gensight-biologics-reports-positive-additional-data-from-reverse-phase-3-clinical-trial-of-gs010-for-treatment-of-leber-hereditary-optic-neuropathy-lhon/2480100/GenSight Biologics reported additional results from the REVERSE phase 3 clinical trial evaluating the safety and efficacy of a single intravitreal injection of GS010 (rAAV2/2-ND4)in patients with Leber Hereditary Optic Neuropathy (LHON). The study involved 37 patients with visual loss du
- Ophthalmologists Issue Eye Safety Warning Ahead of Fireworkshttps://modernod.com/news/ophthalmologists-issue-eye-safety-warning-ahead-of-fireworks-severy-year-about-10000-people-are-rushed-to-the-emergency-department-for-fireworks-injuries-ophthalmologists-physicians-who-s/2480108/Every year, about 10,000 people are rushed to the emergency department for fireworks injuries. Ophthalmologists treat thousands of patients who suffer a range of fireworks-related injuries, from cuts and bruises to damaged corneas, retinas, and ruptured eyeballs. Many people believe that consumer